Add like
Add dislike
Add to saved papers

Improving anti thrombogenicity of nanofibrous polycaprolactone through surface modification.

To improve anti thrombogenicity of polycaprolactone, nanofibrous mat of this synthetic polymer is prepared by electrospinning method. Subsequently, plain electrospun nanofibrous polycaprolactone was treated by RF oxygen plasma to initiate the graft copolymerization with acrylamide monomers. The surface morphology and average fiber diameter of plain electrospun nanofibrous polycaprolactone were determined by scanning electron microscopy technique. The chemical composition and surface characteristics of the samples were examined by static contact angle measurements, and attenuated total reflectance Fourier transfer infrared (ATR-FTIR) spectroscopy. Atomic force microscopy was employed to investigate the effect of plasma treatment and graft copolymerization on the surface roughness and topography of the samples. Mechanical properties were measured from the stress-strain curve. The amount of platelet adhesion was observed by scanning electron microscopy images. Results indicate that the polycaprolactone synthetic polymer was successfully electrospun with a nanofibrous micro structure. The ATR-FTIR spectrum confirmed the influence of RF oxygen plasma treatment and graft copolymerization. Contact angle outcomes exhibited a massive improvement in the hydrophilic property of the polycaprolactone-plasma-acrylamide sample, and the surface roughness of this sample also decreased dramatically as atomic force microscopy results showed. The mechanical property of the polycaprolactone-plasma-acrylamide sample shows a negligible reduction in comparison with plain electrospun polycaprolactone. The polycaprolactone-plasma-acrylamide sample possesses proper values of mechanical properties compared to natural blood vessels. The SEM images of polycaprolactone, polycaprolactone-plasma, and polycaprolactone-plasma-acrylamide revealed no adhesion of natural platelets for polycaprolactone-plasma-acrylamide. Thus, the polycaprolactone-plasma-acrylamide vascular prosthesis is fabricated and post processed with sufficient surface properties and anti thrombogenicity.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app